SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH - Medical Device Manufacturer in Indonesia
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH from Germany is a medical device manufacturer with 20 registered products in the Indonesia BPOM database through Pure Global AI's free platform. The company produces 20 unique product types across 2 product classes.
This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.
Kelas : 2
SIEMENS N Protein Control LC1
N Latex ADnase B
SIEMENS N Protein Control LC2
SIEMENS N Antiserum to Human Fibrinogen
SIEMENS N Antiserum to Human Antithrombin III
... and 14 more products in this class
Kelas : 1
IMMULITE Probe Wash Module
Kelas : 1
Jan 7, 2025
SIEMENS N Protein Control LC1
Kelas : 2
Sep 20, 2024
N Latex ADnase B
Kelas : 2
Sep 20, 2024
SIEMENS N Protein Control LC2
Kelas : 2
Sep 20, 2024
SIEMENS N Antiserum to Human Fibrinogen
Kelas : 2
Sep 20, 2024
SIEMENS N Antiserum to Human Antithrombin III
Kelas : 2
Sep 12, 2024
SIEMENS N Sample Diluent
Kelas : 2
Sep 12, 2024
SIEMENS N/T N Latex Ferritin
Kelas : 2
Sep 11, 2024
SIEMENS N Antiserum to Human Hemopexin
Kelas : 2
Sep 9, 2024
SIEMENS N Latex IgE mono
Kelas : 2
Sep 9, 2024
SIEMENS N Antiserum to Human Alpha-1-acid Glycoprotein
Kelas : 2
Sep 2, 2024
SIEMENS N a1-Microglobulin Kit
Kelas : 2
Aug 31, 2024
SIEMENS N Lp(a) Standard SY
Kelas : 2
Aug 31, 2024
SIEMENS N Antiserum to Human Retinol-binding Protein (RbP)
Kelas : 2
Aug 19, 2024
INNOVANCE Free PS Ag
Kelas : 2
Mar 25, 2024
SIEMENS N Antiserum to Human C3c
Kelas : 2
Feb 5, 2024
SIEMENS N Antiserum to Human Fibronectin
Kelas : 2
Feb 1, 2024
SIEMENS N Latex FLC Kappa
Kelas : 2
Jan 27, 2024
SIEMENS N FLC Control SL
Kelas : 2
Jan 25, 2024
SIEMENS N Antiserum to Human C4
Kelas : 2
Jan 25, 2024

